Publicaciones en colaboración con investigadores/as de French Institute of Health and Medical Research (4)

2001

  1. Low doses of Epo activate MAP Kinases but not JAK2 - STAT5 in rat vascular smooth muscle cells

    Biochemical and Biophysical Research Communications, Vol. 284, Núm. 4, pp. 1031-1038

  2. S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist

    Endocrinology, Vol. 142, Núm. 9, pp. 3950-3963

2000

  1. Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation

    Oncogene, Vol. 19, Núm. 41, pp. 4695-4705

  2. Involvement of prolactin in breast cancer: Redefining the molecular targets

    Experimental Gerontology, Vol. 35, Núm. 1, pp. 41-51